Where is the live CopyMark page for USPTO serial 79046217?

The live record is at https://getcopymark.com/trademark/79046217. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns Serial No. 79046217?

According to the public USPTO record for serial number 79046217, the listed owner(s) include: Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG.

What is USPTO serial number 79046217?

Serial number 79046217 is the USPTO application identifier for the mark Serial No. 79046217. It is used to track examination, publication, and registration of this trademark.

What is the current status of Serial No. 79046217?

Serial No. 79046217 (79046217) currently shows USPTO status code 404 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover Serial No. 79046217?

The public record lists International Classes: 005, 042. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: Serial No. 79046217 Serial# 79046217 | status 404; last event UNDN | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79046217?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JAMES A. THOMAS

JAMES A. THOMAS TROUTMAN SANDERS LLPTWO HANNOVER SQ434 FAYETTEVILLE ST STE 1900RALEIGH, NC 27601

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations and substances for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, the cardiovascular system, the musculoskeletal system, the central nervous system, the peripheral nervous system, the genitourinary system, the respiratory system, and dermatological disorders; hormones for medical purposes; anti-infective preparations; anti-viral preparations; cytostatic preparations for use in the treatment of cancer	SECTION 71 - CANCELLED	—
042	Conducting clinical studies for pharmaceutical preparations	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Mar 31, 2017	UNDN	UNDELIVERABLE MAIL - NO ACTION TAKEN	—
Feb 24, 2017	DENC	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED	—
Feb 24, 2017	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Dec 2, 2016	C71T	CANCELLED SECTION 71	—
Feb 5, 2013	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Aug 9, 2010	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Aug 9, 2010	FIMP	FINAL DISPOSITION PROCESSED	—
Jul 27, 2010	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Apr 27, 2010	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 9, 2010	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 20, 2010	NPUB	NOTICE OF PUBLICATION	—
Jan 6, 2010	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Jan 6, 2010	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Jan 6, 2010	CNEA	EXAMINERS AMENDMENT MAILED	—
Jan 6, 2010	XAEC	EXAMINER'S AMENDMENT ENTERED	—
Jan 6, 2010	CNEA	EXAMINERS AMENDMENT -WRITTEN	—
Nov 12, 2009	ZZZX	PREVIOUS ALLOWANCE COUNT WITHDRAWN	—
Nov 9, 2009	PBCR	WITHDRAWN FROM PUB - OG REVIEW QUERY	—
Oct 28, 2009	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Oct 26, 2009	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Oct 2, 2009	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Oct 1, 2009	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Oct 1, 2009	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 25, 2009	CHLD	CHANGE OF OWNER RECEIVED FROM IB	—
Jun 11, 2009	OPNX	NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB	—
May 7, 2009	OPNS	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	—
May 7, 2009	OPNR	NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB	—
Apr 1, 2009	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2009	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2009	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2009	PCGR	PETITION TO DIRECTOR GRANTED	—
Mar 16, 2009	ACEC	AMENDMENT FROM APPLICANT ENTERED	—
Mar 16, 2009	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Mar 14, 2009	ALIE	ASSIGNED TO LIE	—
Mar 12, 2009	FAXX	FAX RECEIVED	—
Oct 2, 2008	APET	ASSIGNED TO PETITION STAFF	—
Aug 26, 2008	PCRC	PETITION TO DIRECTOR RECEIVED	—
Aug 26, 2008	MAIL	PAPER RECEIVED	—
Aug 26, 2008	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Aug 25, 2008	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Aug 25, 2008	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 25, 2008	TCCA	TEAS CHANGE OF CORRESPONDENCE RECEIVED	—
May 1, 2008	OPNX	NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB	—
Mar 14, 2008	RFNT	REFUSAL PROCESSED BY IB	—
Feb 25, 2008	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Feb 25, 2008	RFRR	REFUSAL PROCESSED BY MPU	—
Feb 25, 2008	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Feb 24, 2008	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2008	DOCK	ASSIGNED TO EXAMINER	—
Dec 10, 2007	NWAP	NEW APPLICATION ENTERED	—
Dec 7, 2007	LIMS	LIMITATION OF GOODS/SERVICES FROM IB ENTERED	—
Dec 6, 2007	SDRC	SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB	—

Serial No. 79046217